Pharmacia Drug Patent Portfolio
Pharmacia owns 2 orange book drugs protected by 9 US patents Given below is the list of Pharmacia's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6455574 | Therapeutic combination | 11 Aug, 2018 | Expired |
| US5849535 | Human growth hormone variants | 25 Mar, 2017 | Expired |
| US5969156 | Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) | 08 Jan, 2017 | Expired |
| US5969156 | Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) | 08 Jul, 2016 | Expired |
| US6057292 | Method for inhibiting growth hormone action | 21 Sep, 2015 | Expired |
| US5686104 | Stable oral CI-981 formulation and process of preparing same | 11 May, 2015 | Expired |
| US5686104 | Stable oral CI-981 formulation and process of preparing same | 11 Nov, 2014 | Expired |
| US6126971 | Stable oral CI-981 formulation and process for preparing same | 19 Jul, 2013 | Expired |
| US6126971 | Stable oral CI-981 formulation and process for preparing same | 19 Jan, 2013 | Expired |
Pharmacia's Family Patents
Pharmacia Drug List
Given below is the complete list of Pharmacia's drugs and the patents protecting them.
1. Caduet
Caduet is protected by 7 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6455574 | Therapeutic combination |
11 Aug, 2018
(6 years ago)
| Expired |
| US5969156
(Pediatric)
| Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
08 Jan, 2017
(7 years ago)
| Expired |
| US5969156 | Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
08 Jul, 2016
(8 years ago)
| Expired |
| US5686104
(Pediatric)
| Stable oral CI-981 formulation and process of preparing same |
11 May, 2015
(9 years ago)
| Expired |
| US5686104 | Stable oral CI-981 formulation and process of preparing same |
11 Nov, 2014
(9 years ago)
| Expired |
| US6126971
(Pediatric)
| Stable oral CI-981 formulation and process for preparing same |
19 Jul, 2013
(11 years ago)
| Expired |
| US6126971 | Stable oral CI-981 formulation and process for preparing same |
19 Jan, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Caduet's drug page
2. Somavert
Somavert is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5849535 | Human growth hormone variants |
25 Mar, 2017
(7 years ago)
| Expired |
| US6057292 | Method for inhibiting growth hormone action |
21 Sep, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Somavert's drug page